// App-Quantinova.ai

67 : CTLA-4 Polymorphisms: Influence on Transplant-Related Mortality and Survival in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Researchers

Presenter

  • Bernd Gruhn

Principal Investigators

  • Susan Wittig

  • Thomas Ernst

Medical Centers

  • Department of Pediatrics, Jena University Hospital, Jena, Germany

  • Department of Obstetrics and Gynecology, Universitatsklinikum Halle, Halle, Germany

  • Klinik fur Kinder und Jugendmedizin, Universitatsklinikum Ulm, Ulm, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Leukemia, juvenile myelomonocytic

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • Cyclosporine A

  • Methotrexate

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved